I recall a talk on imaging biomarkers for Alzheimer’s disease (AD). “Take this with a pinch of salt. I have a financial conflict of interest (COI) in the success of these markers,” the speaker warned. I glanced at the audience — MDs and PhDs with a cumulative IQ higher than the French intake of wine. […]
via Medicine Joint Channels
No hay comentarios:
Publicar un comentario